Are mesenchymal stem cells and derived extracellular vesicles valuable to halt the COVID-19 inflammatory cascade? Current evidence and future perspectives

Thorax. 2021 Feb;76(2):196-200. doi: 10.1136/thoraxjnl-2020-215717. Epub 2020 Dec 15.
No abstract available

Keywords: ARDS; cytokine biology; pneumonia; respiratory infection; viral infection.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • COVID-19 / epidemiology
  • COVID-19 / pathology*
  • Extracellular Vesicles*
  • Humans
  • Inflammation / pathology*
  • Mesenchymal Stem Cells / cytology*
  • SARS-CoV-2